Impact of Nuclear Interleukin-1 Alpha and EGFR Expression on Recurrence and Survival Outcomes in Oral Squamous Cell Carcinomas

Figure 7

Prognostic impact by combined EGFR/IL-1α expression scores. Shown are Kaplan-Meier estimates of overall survival (a,c,e) and progression-free survival (b,d,f) according to EGFR expression scores and 2/1 (a,b), 1/1 (c,d) and 1/0 (e,f) IL-1α scores. HR: hazard ratio, CI: 95% confidence interval. NR: not reached.

(a)

(b)

(c)

(d)

(e)

(f)